1887
Research article Open Access
Like 0

Abstract

Real-world estimates of seasonal influenza vaccine effectiveness (VE) are important for early detection of vaccine failure. We developed a method for evaluating real-time in-season vaccine effectiveness (IVE) and overall seasonal VE. In a retrospective, register-based, cohort study including all two million individuals in Stockholm County, Sweden, during the influenza seasons from 2011/12 to 2014/15, vaccination status was obtained from Stockholm’s vaccine register. Main outcomes were hospitalisation or primary care visits for influenza (International Classification of Disease (ICD)-10 codes J09-J11). VE was assessed using Cox multivariate stratified and non-stratified analyses adjusting for age, sex, socioeconomic status, comorbidities and previous influenza vaccinations. Stratified analyses showed moderate VE in prevention of influenza hospitalisations among chronically ill adults ≥ 65 years in two of four seasons, and lower but still significant VE in one season; 53% (95% confidence interval (CI): 33–67) in 2012/13, 55% (95% CI: 25–73) in 2013/14 and 18% (95% CI: 3–31) in 2014/15. In conclusion, seasonal influenza vaccination was associated with substantial reductions in influenza-specific hospitalisation, particularly in adults ≥ 65 years with underlying chronic conditions. With the use of population-based patient register data on influenza-specific outcomes it will be possible to obtain real-time estimates of seasonal influenza VE.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.43.30381
2016-10-27
2017-11-23
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.43.30381
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/43/eurosurv-21-30381-3.html?itemId=/content/10.2807/1560-7917.ES.2016.21.43.30381&mimeType=html&fmt=ahah

References

  1. Valenciano M, Ciancio BI-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):20281. PMID: 23041022 
  2. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010;28(46):7381-8.  https://doi.org/10.1016/j.vaccine.2010.09.010  PMID: 20851086 
  3. Belongia EA, Shay DK. Influenza vaccine for community-acquired pneumonia. Lancet. 2008;372(9636):352-4.  https://doi.org/10.1016/S0140-6736(08)61137-X  PMID: 18675671 
  4. Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951-9.  https://doi.org/10.1093/cid/cis574  PMID: 22843783 
  5. Pebody RG, Mølbak K. Importance of timely monitoring of seasonal influenza vaccine effectiveness. Euro Surveill. 2016;21(16):30209.  https://doi.org/10.2807/1560-7917.ES.2016.21.16.30209  PMID: 27123870 
  6. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010; (2):CD004876. PMID: 20166072 
  7. Beyer WEP, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus ADME. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31(50):6030-3.  https://doi.org/10.1016/j.vaccine.2013.09.063  PMID: 24095882 
  8. Carlsson AC, Wändell P, Ösby U, Zarrinkoub R, Wettermark B, Ljunggren G. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health. BMC Public Health. 2013;13(1):670.  https://doi.org/10.1186/1471-2458-13-670  PMID: 23866784 
  9. JSzegö J. Bebyggelsens mosaik [The mosaic of the settlement]. Rapport 7:2009. Stockholm: Regionplanekontoret; 2009. Swedish. Available from: http://www.rufs.se/publikationer/20092/20097-bebyggelsens-mosaik/
  10. World Health Organization (WHO). International statistical classification of diseases and related health problems. 10th Revision. Volume 2. Instruction manual. 2010 ed. Geneva: WHO; 2011. Available from: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf
  11. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450.  https://doi.org/10.1186/1471-2458-11-450  PMID: 21658213 
  12. Public Health Agency of Sweden Influenza in Sweden 2014-2015 Season. [Accessed 5 Aug 2016] Available from: https://www.folkhalsomyndigheten.se/pagefiles/21868/Influenza-in-Sweden-2014-2015.pdf
  13. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-44.  https://doi.org/10.1093/ije/dyi274  PMID: 16368725 
  14. Örtqvist A, Granath F, Askling J, Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J. 2007;30(3):414-22.  https://doi.org/10.1183/09031936.00135306  PMID: 17537767 
  15. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007; (2):CD001269. PMID: 17443504 
  16. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29(49):9159-70.  https://doi.org/10.1016/j.vaccine.2011.08.008  PMID: 21840359 
  17. Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013;178(8):1327-36.  https://doi.org/10.1093/aje/kwt124  PMID: 23978527 
  18. Remschmidt C, Wichmann O, Harder T. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis. 2015;15(1):429.  https://doi.org/10.1186/s12879-015-1154-y  PMID: 26474974 
  19. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661-5.  https://doi.org/10.1001/jama.1994.03520210045030  PMID: 7966893 
  20. Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, et al. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol. 2014;67(7):734-44.  https://doi.org/10.1016/j.jclinepi.2014.02.009  PMID: 24768004 
  21. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014;59(10):1375-85.  https://doi.org/10.1093/cid/ciu680  PMID: 25270645 
  22. Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA. 2004;292(17):2089-95.  https://doi.org/10.1001/jama.292.17.2089  PMID: 15523069 
  23. Kissling E, Valenciano MI-MOVE Case-Control Studies Team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill. 2012;17(15):20146. PMID: 22516046 
  24. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013;18(5):20390. PMID: 23399425 
  25. Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horváth JK, Donnell JM, et al. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015;33(24):2813-22.  https://doi.org/10.1016/j.vaccine.2015.04.012  PMID: 25936723 
  26. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015;64(1):10-5. PMID: 25590680 
  27. Pebody R, Warburton F, Andrews N, Ellis J, von Wissmann B, Robertson C, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015;20(36):30013.  https://doi.org/10.2807/1560-7917.ES.2015.20.36.30013  PMID: 26535911 
  28. Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, et al. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season. Clin Infect Dis. 2016;63(1):21-32.  https://doi.org/10.1093/cid/ciw176  PMID: 27025838 
  29. World Health Organisation (WHO). Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season. [Accessed 10 May 2016]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201409_recommendation.pdf
  30. European Commission. Council Recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/EU) Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 29.12.2009:L 348/71. Available from: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32009H1019
  31. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014;19(6):20701.  https://doi.org/10.2807/1560-7917.ES2014.19.6.20701  PMID: 24556348 
  32. Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 2015;20(2):21011.  https://doi.org/10.2807/1560-7917.ES2015.20.2.21011  PMID: 25613779 
  33. Smittskydd Stockholm. Influensasäsongen 2015-2016 [Influenza season 2015-2016]. 27 June 2015. Available from: http://www.vardgivarguiden.se/behandlingsstod/smittskydd/dokument/statistik/influensa/influensasasongen-2015-2016/
/content/10.2807/1560-7917.ES.2016.21.43.30381
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error